Results 41 to 50 of about 77,178 (229)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)

open access: yesCurrent Oncology, 2023
Aim: The gold standard of care for pancreatic adenocarcinoma is the integrated treatment of surgery and chemotherapy (ChT), but about 50% of patients present with unresectable disease.
Tiziana Comito   +18 more
doaj   +1 more source

Resección de meningiomas en diferente localización (temporal y sellar) mediante craneotomía única reporte de un caso y revisión de la literatura

open access: yesCirugía y Cirujanos, 2021
Meningiomas are the most frequent extra-axial tumors of the nervous system. Multiple meningiomas are defined as the presence of two or more lesions that appear simultaneously or not, in different intracranial location, without association to ...
José L Navarro-Olvera   +4 more
doaj   +1 more source

Monitoring Frequency of Intra‐Fraction Patient Motion Using the ExacTrac System for LINAC‐based SRS Treatments [PDF]

open access: yes, 2018
Purpose: The aim of this study was to investigate the intra‐fractional patient motion using the ExacTrac system in LINAC‐based stereotactic radiosurgery (SRS).
Kim, Siyong   +3 more
core   +2 more sources

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife. [PDF]

open access: yes, 2013
Treatment plans for prostate cancer patients undergoing stereotactic body radiation therapy (SBRT) are often challenging due to the proximity of organs at risk.
Carrara, Mauro   +10 more
core   +2 more sources

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy

open access: yesBMC Cancer, 2017
Background To appraise the ability of a radiomics based analysis to predict local response and overall survival for patients with hepatocellular carcinoma.
Luca Cozzi   +12 more
doaj   +1 more source

Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes

open access: yesAdvances in Radiation Oncology, 2021
Purpose: This study aims to develop a local control risk stratification using recursive partitioning analysis (RPA) for patients receiving stereotactic body radiation therapy (SBRT) for metastatic cancer.
Roman O. Kowalchuk, MD   +9 more
doaj   +1 more source

The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma [PDF]

open access: yes, 2015
The melanoma-specific graded prognostic assessment (msGPA) assigns patients with brain metastases from malignant melanoma to 1 of 4 prognostic groups.
A Likhacheva   +36 more
core   +2 more sources

Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer

open access: yesRadiation Oncology, 2017
Background The aim of this review is the critical appraisal of the current use of volumetric modulated arc therapy for the radiation therapy management of breast cancer. Both clinical and treatment planning studies were investigated. Material and methods
Luca Cozzi   +8 more
doaj   +1 more source

Cerebral arteriovenous malformations : usability of Spetzler-Martin and Spetzler-Ponce scales in qualification to endovascular embolisation and neurosurgical procedure [PDF]

open access: yes, 2018
Purpose: Arteriovenous malformations (AVMs) are connected with cerebral haemorrhage, seizures, increased intracranial pressure, headaches, mass effect, and ischaemia symptoms.
Baron, Jan   +8 more
core   +1 more source

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

open access: yesThoracic Cancer, 2023
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj   +1 more source

Home - About - Disclaimer - Privacy